Physiology and bone physiopathology;Fisiología y fisiopatología ósea

Anales del Sistema Sanitario de Navarra

Volumn 26, Issue SUPPL. 3, 2003, Pages 7-17

  Lafita, Javier ^a  

^a Centro de Consultas Principe de Viana   (Spain)

Author keywords

Bone physiopathology; Osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOCHEMICAL MARKER; COLONY STIMULATING FACTOR 1; DEOXYPYRIDINOLINE; FIBROBLAST GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYLYSINE; HYDROXYPROLINE; INTERLEUKIN 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN GLUCOSYLTRANSFERASE; PROSTAGLANDIN E2; PYRIDINOLINE; SIALOPROTEIN; TELOPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

BONE FRAGILITY; BONE MARROW; BONE MINERAL; BONE REMODELING; BONE STRUCTURE; CLINICAL FEATURE; CYTOARCHITECTURE; FUNCTIONAL ANATOMY; HUMAN; MINERALIZATION; MOVEMENT (PHYSIOLOGY); MUSCLE TISSUE; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMIC DISEASE;

BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE REMODELING; BONE RESORPTION; HUMANS; OSTEOPOROSIS; RISK FACTORS;

EID: 0742318958     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Osteoporosis prevention, diagnosis, and Therapy. NIH Consensus Stratement 2000; 17: 1-45. Accesed at htt://odp.od.nih.gov/consensus/cons/111/111_statement.htm.
2. MELTON LJ, KAN SH, FRYE MA, WAHNER HW, O'FALLON WM, RIGGS BL. Epidemiology of vertebral fractures in wome. Am J Epidemiol 1989; 129: 1000-1011.
3. EDDY D, JOHNSTON CC, CUMMINGS SR. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoposos Int 1998; 8 (Suppl 4): 1-88.
4. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1993; 94: 646-650.
5. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. World Health Organitation. WHO Technical Report Series 843. Geneva: Worl Health Organitation; 1994.
6. DIAZ CURIEL, M, CARRASCO DE LA PEÑA JL, HONORATO PEREZ J, PEREZ CANO R, RAPADO A, RUIZ MARTÍNEZ I. Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis. Osteoporosis Int 1997; 7: 59-64.
7. LAWRENCE G, RAISZ MD, GIDEON A, ROLDAN. Pathogenesis of osteoporosis. Endocrinol Metab Clin N Am 2003; 32: 15-24.
8. CARTER DR, BOUXSEIN ML, MARCUS R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992; 7: 137-145.
9. JERGAS M, BRETTENSEHER M, GLUER CC, YU W, GENANT HK. Estimates of volumetric bone density from projectional measurements improve the discriminatory capability of dual X-ray absortiometry. J Bone Miner Res 1995; 10: 1101-1110.
10. HANGARTNER TN, GILSANZ V. Evaluation of cortical bone by computed tomography. J Bone Miner Res 1996; 11; 1518-1525.
11. THEINTZ G, BUCHS B, RIZZOLI R, SLOSMAN D, CLAVIEN H, SIZONENKO PC et al. Longitudinal monitoring of bone mass acculation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75: 1060-1065.
12. MOSEKILDE L, MOSEKILDE L. Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone 1990; 11: 67-73.
13. RECKER RR, DAVIES KM, HINDERS SM, HEANEY RP, STEGMAN MR, KIMMEL DB. Bone gain in young adult women. JAMA 1992; 268: 2403-2408.
14. KATZMAN DK, BACHRACH LK, CARTER DR, MARCUS R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991; 73: 1332-1339.
15. MORA S, GILSANZ V. Establishment of peak bone mass. Endocrinol Metab Clin N Am 2003; 32: 39-63.
16. CARTER DR, VAN DER MEULEN MCH, BEAUPRE GS. Skeletal development: mechanical consequences of growth, aging and disease. En: Marcus R. Feldman D, Kelsey J, edit. Osteoporosis. San Diego: Academic Press; 1996: 333-350.
17. PEACOCK M, TURNER CHH, ECONS MJ, FOROUD T. Genetics of osteoporosis. Endocr Rev 2002; 23: 303-326.
18. GILSANZ V, SKAGGS DL, KOVANLIKAYA A, SAYRE J, LORO ML, KAUFMAN F et al. Differential effect of race on the axial and appendicular skeletons in children. J Clin Endocrinol Metab 1998; 83: 1420-1427.
19. CARANI C, QIN K, SIMONI M, FAUSTINI-FUSTINI M, SERPENTE S, BOYD J et al. Effect of testosterona and estradiol in a man with aromatasa deficiency. N Engl J Med 1997; 337: 91-95.
20. KHOSLA S. The OPG/RANKL/RANK system. Endocrinology 2001; 142: 5050-5055.
21. RIGGS BL, SUNDEEP K, MELTON III J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002; 23: 279-302.
22. CUMMINGS SR, KARPF DB, HARRIS F, GENANT HK, ENSRUD K, LACROIX AZ et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002; 112: 281-289.
23. TONTONOZ P, HU E, SPIEGELMAN BM. Stimulation of adipogenesis in fibroblast by PPAR? 2, a lipid activated transcription factor. Cell 1994; 79: 1147-1156.
24. LANGLOIS JA, ROSEN CJ, VISSER M, HANNAN MT, HARRIS T, WILSON PW et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 1998; 83: 4257-4262.
25. CANALIS E, ECONOMIDES AN, GAZZERRO E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 2003; 24: 218-235.
26. MANOLAGAS SC. Birth and death of bone cells: basic regulatory mechanism and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115-137.
27. FROST HM. Perspective on the estrogen-bone relationship and postmenopausal bone loss. J Bone Miner Res 1999; 14: 1473-1477.
28. SEIBEL MJ. Biochemical markers of bone remodeling. Endocrinol Metab Clin N Am 2003; 32: 83-113.
29. American Association of Clinical Endocrinologist 2001. Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. Endocr Pract 2001; 7: 293-312.